We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Acerca del Thinksulin

Thinksulin

Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2017); clinician and consumer consultations; and clinical expertise.

Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.

Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.

Novedades de Última Versión 1.0.102

Last updated on 22/11/2020

Lantus insulin was discontinued from 1st July 2020. Optisulin and Semglee are available alternative forms of insulin glargine, and this has been reflected in this version.

Enhancements & Bugfixes

Traductorio...

Información Adicional de Aplicación

Última Versión

Solicitar Thinksulin Actualización 1.0.102

Presentado por

Than Htike

Requisitos

Android 5.0+

Available on

Conseguir Thinksulin desde Google Play

Mostrar más

Thinksulin Capturas de pantalla

Suscríbete a APKPure
Sé el primero en obtener acceso al lanzamiento anticipado, noticias y guías de los mejores juegos y aplicaciones de Android.
No, gracias
Suscribirme
¡Suscrito con éxito!
Ahora estás suscrito a APKPure.
Suscríbete a APKPure
Sé el primero en obtener acceso al lanzamiento anticipado, noticias y guías de los mejores juegos y aplicaciones de Android.
No, gracias
Suscribirme
¡Éxito!
Ya estás suscrito a nuestro boletín electrónico.